Home » Topics » Regulatory

Regulatory
RSS

Orencia approved for rheumatoid arthritis

Dec. 28, 2005

Nexavar receives FDA approval for advanced renal cell carcinoma

Dec. 22, 2005

Depakote ER receives new approval in bipolar disorder

Dec. 19, 2005

Iplex approved for severe primary IGF-1 deficiency

Dec. 15, 2005

Korean approval for udenafil in erectile dysfunction

Dec. 1, 2005

U.K. approval for MT-100 for migraine

Nov. 29, 2005

Metvix approved for Bowen's disease in Europe

Nov. 29, 2005

Effexor XR approved for adults with panic disorder

Nov. 22, 2005

BioMimetic's GEM-21S approved for periodontal bone defects

Nov. 22, 2005

Shanghai Sunway Biotech's H101 approved for refractory nasopharyngeal cancer

Nov. 18, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...